Elephas Platform
Elephas is a biotechnology platform developed by Elephas Biosciences Corporation. It provides real-time functional insights and response predictions from live human tissue samples, particularly focused on oncology and pharmaceutical research.
Core Technology: elive™ Platform
The elive™ platform is designed to predict immunotherapy response directly from standard-of-care core needle biopsies. The process is streamlined into three key steps:
- Prepare: Standard biopsies are prepared using a proprietary automated cutting instrument and a specialized gel. This unique method maintains tissue viability throughout the assessment on the elive™ platform.
- Assess: The platform uses a sequential treatment strategy to accurately measure changes in cytokine response. This approach helps mitigate challenges related to tissue heterogeneity and low sample volume.
- Result: Clinicians and researchers receive detailed reports through a secure, cloud-based application. Reports can be customized to project needs, including summaries of key findings and raw data for further analysis.
Key Features and Applications
- For Medical Oncologists: The elive™ Test allows doctors to see how a patient's tumor will respond to treatment before administering therapy, enabling more personalized and effective care.
- For Pharma R&D: Pharmaceutical companies can use the platform to de-risk pipeline decisions, optimize clinical trial designs, and identify likely responders to new therapies.
- For Research Scientists: The technology enables the maintenance and profiling of live human tissue, allowing researchers to measure the dynamic tissue microenvironment in its native biological context.
Partnership Models
Elephas offers flexible partnership options to meet diverse needs, including:
- Deploying the elive™ platform within your own laboratory.
- Commissioning custom studies to be performed in their facility.
- Purchasing or leasing individual platform components.
- Joining the early access program for the elive™ Test.
The platform is developed by a team with expertise in clinical settings, pharmaceutical development, and research, making it a robust tool for advancing precision medicine.
